When stratified by APOE ε4 status, the conversion rate from amyloid CL value positive to negative status was higher in non‐carriers than in carriers, although the differences did not reach statistical significance (Figure 4C,D ).
← all excerpts
Effectiveness, safety, and biomarker dynamics of lecanemab in Chinese Alzheimer's disease population: a multicenter real-world study.
1
—
—